1 |
von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990;66:587-92.
DOI
|
2 |
Price LC, Seckl MJ, Dorfmuller P, Wort SJ. Tumoral pulmonary hypertension. Eur Respir Rev 2019;28:pii: 180065.
|
3 |
Price LC, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy. Curr Opin Pulm Med 2016;22:421-8.
DOI
|
4 |
Chun YS, Pawlik TM, Vauthey JN. 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol 2018;25:845-7.
DOI
|
5 |
Fujishiro T, Shuto K, Shiratori T, Kono T, Akutsu Y, Uesato M, et al. A case report of pulmonary tumor thrombotic microangiopathy (PTTM) caused by esophageal squamous cell carcinoma. Esophagus 2013;10:247-51.
DOI
|
6 |
Patrignani A, Purcaro A, Calcagnoli F, Mandolesi A, Bearzi I, Ciampani N. Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis. J Cardiovasc Med (Hagerstown) 2014;15:828-33.
DOI
|
7 |
Godbole RH, Saggar R, Kamangar N. Pulmonary tumor thrombotic microangiopathy: a systematic review. Pulm Circ 2019;9:2045894019851000.
|
8 |
Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H, Miyamoto A, et al. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med 2013;52:1317-23.
DOI
|